Switch to:
More From Other Websites
ArQule To Report Second Quarter 2016 Financial Results On August 3, 2016 Jul 20 2016
ArQule Presents Preclinical Data for ARQ 531, a Proprietary Reversible Inhibitor of Wild Type and... Jul 18 2016
ArQule to Present at Cantor Fitzgerald’s 2nd Annual Healthcare Conference on July 12, 2016 Jul 05 2016
Here’s What The ArQule, Inc. (ARQL) Data Really Means Jul 01 2016
ArQule Presents Preliminary Clinical Data for ARQ 087 Demonstrating Evidence of Anticancer Activity... Jun 30 2016
Forget Valeant, Invest in These Attractive Drug Stocks Instead Jun 28 2016
ArQule (ARQL) Shows Strength: Stock Adds 8% in Session Jun 23 2016
ArQule to Present Preliminary Phase 1/2 Data for FGFR Inhibitor, ARQ 087, in Intrahepatic... Jun 23 2016
ETF’s with exposure to ArQule, Inc. : June 20, 2016 Jun 20 2016
ArQule: Advancing a Deep and Diverse Clinical Stage Pipeline Jun 20 2016
ARQULE INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders May 26 2016
ArQule, Inc. :ARQL-US: Earnings Analysis: Q1, 2016 By the Numbers May 17 2016
ARQULE INC Financials May 10 2016
Edited Transcript of ARQL earnings conference call or presentation 4-May-16 1:00pm GMT May 04 2016
ARQULE INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements... May 04 2016
ArQule reports 1Q loss May 04 2016
ArQule reports 1Q loss May 04 2016
Q1 2016 ArQule Inc Earnings Release - Before Market Open May 04 2016
ArQule Reports First Quarter 2016 Financial Results May 04 2016
ArQule To Report First Quarter 2016 Financial Results On May 4, 2016 May 03 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)